-
.17drug candidates
brought forward from discovery research since 2010
-
.2dossiers
for rectal artesunate suppositories submitted for WHO prequalification by Cipla and Strides
-
.>200,000doses
of Eurartesim® (dihydroartemisinin-piperaquine), co-developed with Sigma-Tau, distributed in two ground-breaking mass drug administration pilots in Zambia and Mozambique
